Newly‐developed vitiligo following COVID‐19 mRNA vaccine
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Journal of Cosmetic Dermatology - 21(2022), 4, Seite 1350-1351 |
Beteiligte Personen: |
Uğurer, Ece [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
© 2022 Wiley Periodicals, Inc. |
---|
Umfang: |
2 |
---|
doi: |
10.1111/jocd.14843 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY009116001 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY009116001 | ||
003 | DE-627 | ||
005 | 20230307183819.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230217s2022 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1111/jocd.14843 |2 doi | |
028 | 5 | 2 | |a JOCD_JOCD14843.xml |
035 | |a (DE-627)WLY009116001 | ||
035 | |a (WILEY)JOCD14843 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.93 |2 bkl | ||
084 | |a 58.28 |2 bkl | ||
100 | 1 | |a Uğurer, Ece |e verfasserin |4 aut | |
245 | 1 | 0 | |a Newly‐developed vitiligo following COVID‐19 mRNA vaccine |
264 | 1 | |c 2022 | |
300 | |a 2 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © 2022 Wiley Periodicals, Inc. | ||
700 | 1 | |a Sivaz, Onur |4 aut | |
700 | 1 | |a Kıvanç Altunay, İlknur |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of Cosmetic Dermatology |g 21(2022), 4, Seite 1350-1351 |w (DE-627)WLY009094466 |x 14732165 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2022 |g number:4 |g pages:1350-1351 |g extent:2 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-ASE | ||
936 | b | k | |a 44.93 |q ASE |
936 | b | k | |a 58.28 |q ASE |
951 | |a AR | ||
952 | |d 21 |j 2022 |e 4 |h 1350-1351 |g 2 |